Cardiovascular Safety of ADHD Medications

Stimulant medications, like methylphenidate and amphetamines, have adverse cardiovascular effects, like elevated blood pressure, increasing the risk of cardiovascular events. Join host Geoff Wall as he reviews a new meta-analysis trying to quantify the risk of ADHD medications on cardiovascular outcomes.The GameChangerA large meta-analysis did not find an association between medications for ADHD and cardiovascular disease. Several limitations may interfere with the applicability of these results.Show Segments00:00 - Introductions01:38 - Background on ADHD and Stimulant Medications02:58 - Rationale for Analysis06:42 - Looking at the Meta-Analysis11:44 - The GameChanger: Meta-Analysis Findings17:43 - Connecting to Practice: Addressing Patient Concerns20:00 - Closing RemarksHostGeoff Wall, PharmD, BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthReferences and ResourcesRisk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysisRedeem your CPE or CME hereCPE (Pharmacist)CME (Physician)Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipPrescribers: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the purported mechanism of the potential risk of cardiovascular disease in patients taking stimulant medications2. Discuss the findings of a recent meta-analysis by Zhang et al on cardiovascular disease and stimulant medications0.05 CEU/0.5 HrUAN: 0107-0000-23-016-H01-PInitial release date: 01/03/2023Expiration date: 01/03/2024Additional CPE and CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagram